V212

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V212, covering 2019-11-08 to 2019-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED) [Phase 1]